search
Back to results

Young Adult Congenital Heart Disease Physical Activity Lifestyle Study (YACHD-PALS) (YACHD-PALS)

Primary Purpose

Cardiovascular Disease Other, Physical Activity

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Physical Activity Lifestyle Intervention
Physical Activity Monitoring
Sponsored by
Jamie Jackson
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Cardiovascular Disease Other focused on measuring congenital heart disease, physical activity

Eligibility Criteria

18 Years - 25 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Between the ages of 18-25 (if 18, must no longer be in high school and no longer living at home)
  2. Are diagnosed with moderate or complex structural congenital heart disease
  3. Live within 120 miles of Nationwide Children's Hospital

Exclusion Criteria:

  1. Do no speak or write proficiently in English
  2. Have cognitive impairments that would interfere with the completion of study procedures
  3. Are diagnosed with a genetic syndrome (e.g., Downs, Marfans)
  4. Have been engaged in a formal exercise program within the past 6 months
  5. Underwent open-heart surgery or have had a transcatheter valve replacement in the last 3 months
  6. Are otherwise prohibited by their cardiologist to engage in at least moderate levels of physical activity
  7. Are unable to complete a treadmill-based exercise stress test
  8. Are currently pregnant
  9. Have contraindications for exercise based on an exercise stress test (e.g., exercise-induced arrhythmias or evidence of cardiac ischemia)
  10. >150 min/weekday of moderate-to-vigorous physical activity per the accelerometer
  11. Do not have access or a device for videoconferencing with the coach

Sites / Locations

  • Nationwide Children's Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Fitbit Only

Fitbit + Coaching Sessions

Arm Description

In the Fitbit Only arm, participants will receive their exercise prescription, as devised from their baseline exercise stress test results, and a Fitbit. They will undergo a 9 week (interim) and a 22 week assessment (follow-up).

In the Fitbit + Coaching Sessions arm, participants will receive their exercise prescription, as devised from their baseline exercise stress test results, a Fitbit, and will have 8 sessions with a coach (interventionist) over the course of 20 weeks. They will undergo a 9 week (interim) and a 22 week assessment (follow-up).

Outcomes

Primary Outcome Measures

Moderate to vigorous physical activity
Number of minutes spent in moderate to vigorous physical activity as measured by an accelerometer.

Secondary Outcome Measures

Sedentary behavior
Number of minutes spent being sedentary as measured by an accelerometer.
Exercise tolerance
Maximal oxygen utilization during physical activity as measured by V02max during an exercise stress test.

Full Information

First Posted
October 21, 2019
Last Updated
March 7, 2022
Sponsor
Jamie Jackson
search

1. Study Identification

Unique Protocol Identification Number
NCT04135859
Brief Title
Young Adult Congenital Heart Disease Physical Activity Lifestyle Study (YACHD-PALS)
Acronym
YACHD-PALS
Official Title
Physical Activity Lifestyle Intervention for Young Adults With Congenital Heart Disease
Study Type
Interventional

2. Study Status

Record Verification Date
March 2022
Overall Recruitment Status
Completed
Study Start Date
March 14, 2019 (Actual)
Primary Completion Date
February 9, 2022 (Actual)
Study Completion Date
February 9, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Jamie Jackson

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study will adapt a physical activity lifestyle intervention to emerging adult congenital heart disease (CHD) survivors with the primary goal of increasing physical activity levels. The study will be split into 2 phases. In Phase 1, participants will be asked to complete questionnaires, wear an accelerometer around the waist for 7 days, and undergo an exercise stress test. The accelerometer and exercise stress test will be used to determine whether participants are eligible to be randomized for the intervention study. In Phase 2, participants will be randomized to one of two conditions: 1) receiving a physical activity tracker (a Fitbit) or 2) receiving a Fitbit AND engaging in videoconferencing sessions with a physical activity coach. During Phase 2, participants will also be asked to complete 3 assessments (weeks 9 and 22, and a 6-month follow-up). The week 9 assessment will consist of completing questionnaires and wearing an accelerometer for 7 days. Week 22 will be similar to week 9 with the addition of a final exercise stress test. The 6-month follow-up will mirror the week 9 assessment. Participants who are randomized to the videoconferencing condition will be asked to meet with a physical activity coach 8 times over the course of 20 weeks. Coaches will help participants to (1) change attitudes toward physical activity, (2) increase perception of others' approval of physical activity (e.g., family members, peers), and (3) increase participants' perceived control by troubleshooting barriers and increasing efficacy for physical activity. Coaches will use the Fitbit to facilitate self-monitoring and goal setting. Participants in the intervention arm will be asked to participate in a focus group at the conclusion of the study to share their experiences.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiovascular Disease Other, Physical Activity
Keywords
congenital heart disease, physical activity

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Study includes 2 possible conditions to which participants are randomized: (1) Fitbit only and (2) Fitbit + coaching sessions.
Masking
None (Open Label)
Masking Description
Investigator, research assistants, coaches (interventionists), and participants do not know which condition a participant is in until the condition is revealed (opening an envelope with the condition listed) after the participant consents to Phase 2. Envelopes with the conditions were prepared by the study statistician.
Allocation
Randomized
Enrollment
36 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Fitbit Only
Arm Type
Active Comparator
Arm Description
In the Fitbit Only arm, participants will receive their exercise prescription, as devised from their baseline exercise stress test results, and a Fitbit. They will undergo a 9 week (interim) and a 22 week assessment (follow-up).
Arm Title
Fitbit + Coaching Sessions
Arm Type
Experimental
Arm Description
In the Fitbit + Coaching Sessions arm, participants will receive their exercise prescription, as devised from their baseline exercise stress test results, a Fitbit, and will have 8 sessions with a coach (interventionist) over the course of 20 weeks. They will undergo a 9 week (interim) and a 22 week assessment (follow-up).
Intervention Type
Behavioral
Intervention Name(s)
Physical Activity Lifestyle Intervention
Intervention Description
Coaches work with participants on three elements of behaviors change: (1) changing attitudes towards physical activity; (2) increase perceptions of other people's approval of physical activity for the participants; (3) increase perceptions of control over being physically active. These elements will be delivered using a non-judgmental stance accompanied by promoting appropriate goal-setting.
Intervention Type
Behavioral
Intervention Name(s)
Physical Activity Monitoring
Other Intervention Name(s)
Fitbit
Intervention Description
A physical activity monitor (Fitbit) will be provided to both groups.
Primary Outcome Measure Information:
Title
Moderate to vigorous physical activity
Description
Number of minutes spent in moderate to vigorous physical activity as measured by an accelerometer.
Time Frame
From baseline to follow-up (approximately 22 weeks).
Secondary Outcome Measure Information:
Title
Sedentary behavior
Description
Number of minutes spent being sedentary as measured by an accelerometer.
Time Frame
From baseline to follow-up (approximately 22 weeks).
Title
Exercise tolerance
Description
Maximal oxygen utilization during physical activity as measured by V02max during an exercise stress test.
Time Frame
From baseline to follow-up (approximately 22 weeks).

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
25 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Between the ages of 18-25 (if 18, must no longer be in high school and no longer living at home) Are diagnosed with moderate or complex structural congenital heart disease Live within 120 miles of Nationwide Children's Hospital Exclusion Criteria: Do no speak or write proficiently in English Have cognitive impairments that would interfere with the completion of study procedures Are diagnosed with a genetic syndrome (e.g., Downs, Marfans) Have been engaged in a formal exercise program within the past 6 months Underwent open-heart surgery or have had a transcatheter valve replacement in the last 3 months Are otherwise prohibited by their cardiologist to engage in at least moderate levels of physical activity Are unable to complete a treadmill-based exercise stress test Are currently pregnant Have contraindications for exercise based on an exercise stress test (e.g., exercise-induced arrhythmias or evidence of cardiac ischemia) >150 min/weekday of moderate-to-vigorous physical activity per the accelerometer Do not have access or a device for videoconferencing with the coach
Facility Information:
Facility Name
Nationwide Children's Hospital
City
Columbus
State/Province
Ohio
ZIP/Postal Code
43205
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
33112424
Citation
Williams CA, Wadey C, Pieles G, Stuart G, Taylor RS, Long L. Physical activity interventions for people with congenital heart disease. Cochrane Database Syst Rev. 2020 Oct 28;10(10):CD013400. doi: 10.1002/14651858.CD013400.pub2.
Results Reference
derived

Learn more about this trial

Young Adult Congenital Heart Disease Physical Activity Lifestyle Study (YACHD-PALS)

We'll reach out to this number within 24 hrs